Gracell Biotechnologies
GRCL
$10.25
Share price
0.00%
Change (1 day)
365.91%
Change (1 year)
Categories
Gracell Biotechnologies (GRCL) - P/B ratio
P/B ratio as of May 2024 : 4.37
According to Gracell Biotechnologies's latest financial reports the company has a price-to-book ratio of 4.37.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Gracell Biotechnologies - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.28 | 449.01% |
| 2022-12-31 | 0.7804 | -45.1% |
| 2021-12-31 | 1.42 | -88.92% |
| 2020-12-31 | 12.8 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | -37.96% | 🇺🇸 USA |